Gilder Gagnon Howe & Co’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-17,519	Closed	-$1.63M	–	368
2021 Q4	$1.63M	Sell	17,519 -599,121	-97%	-$39.5M	0.01%	279
2021 Q3	$36.7M	Sell	616,640 -3,124	-0.5%	-$185K	0.19%	116
2021 Q2	$42.3M	Sell	619,764 -4,314	-0.7%	-$281K	0.21%	112
2021 Q1	$43.3M	Sell	624,078 -12,636	-2%	-$972K	0.23%	110
2020 Q4	$48.9M	Sell	636,714 -6,433	-1%	-$482K	0.24%	104
2020 Q3	$48.1M	Buy	643,147 +328,149	+104%	+$21.9M	0.3%	91
2020 Q2	$19.8M	Buy	+314,998	New	+$17.3M	0.16%	120
2019 Q4	–	Sell	-10,558	Closed	-$483K	–	313
2019 Q3	$483K	Sell	10,558 -413	-4%	-$23.2K	0.01%	240
2019 Q2	$643K	Buy	+10,971	New	+$567K	0.01%	240

Gilder Gagnon Howe & Co's ARNA Position: Q1 2022 in Review

Gilder Gagnon Howe & Co sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 17,519 shares — an estimated $1.63M sold.

Gilder Gagnon Howe & Co first reported a position in ARNA in Q2 2019 and held it in 9 quarters. The position peaked at $48.9M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Gilder Gagnon Howe & Co reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 17,519 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.63M.
Gilder Gagnon Howe & Co first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 9 quarters.
Gilder Gagnon Howe & Co's Arena Pharmaceuticals Inc position peaked at $48.9M in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2022, filed 16 May 2022.